No Data
No Data
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Sarepta Therapeutics (SRPT)
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that
Express News | Definitive Healthcare Corp : Jefferies Cuts Target Price to $10 From $12
Definitive Healthcare Corp. (NASDAQ:DH) Q1 2024 Earnings Call Transcript
Definitive Healthcare Is Maintained at Equal-Weight by Barclays
Definitive Healthcare Is Maintained at Equal-Weight by Barclays
Deutsche Bank Adjusts Definitive Healthcare Price Target to $7 From $10, Maintains Hold Rating
Definitive Healthcare (DH) has an average rating of outperform and price targets ranging from $7 to $12, according to analysts polled by Capital IQ.
No Data